NOX4 and renal cell carcinoma: It has also been found that nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) inhibitor protected RCC cells from ferroptosis and NOX4 overexpression increased the sensitivity of RCC cells to erastin treatment [79].